Hillsdale Investment Management Inc. Takes $746,000 Position in Mettler-Toledo International Inc. (NYSE:MTD)

Hillsdale Investment Management Inc. bought a new stake in shares of Mettler-Toledo International Inc. (NYSE:MTD) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 610 shares of the medical instruments supplier’s stock, valued at approximately $746,000.

Other institutional investors have also recently made changes to their positions in the company. JPMorgan Chase & Co. increased its holdings in shares of Mettler-Toledo International by 14.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier’s stock valued at $332,634,000 after purchasing an additional 28,478 shares in the last quarter. M&T Bank Corp increased its holdings in shares of Mettler-Toledo International by 14.3% during the 3rd quarter. M&T Bank Corp now owns 4,926 shares of the medical instruments supplier’s stock valued at $7,387,000 after purchasing an additional 615 shares in the last quarter. Allworth Financial LP grew its stake in Mettler-Toledo International by 367.4% in the 4th quarter. Allworth Financial LP now owns 215 shares of the medical instruments supplier’s stock valued at $285,000 after acquiring an additional 169 shares during the period. Nordea Investment Management AB grew its stake in Mettler-Toledo International by 29.8% in the 4th quarter. Nordea Investment Management AB now owns 105,823 shares of the medical instruments supplier’s stock valued at $129,919,000 after acquiring an additional 24,285 shares during the period. Finally, Robeco Institutional Asset Management B.V. grew its stake in Mettler-Toledo International by 18.0% in the 4th quarter. Robeco Institutional Asset Management B.V. now owns 34,370 shares of the medical instruments supplier’s stock valued at $42,058,000 after acquiring an additional 5,234 shares during the period. 95.07% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on MTD shares. Wells Fargo & Company lifted their price target on shares of Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the company an “equal weight” rating in a research note on Monday, February 10th. Citigroup dropped their price target on shares of Mettler-Toledo International from $1,450.00 to $1,400.00 and set a “neutral” rating on the stock in a research note on Tuesday, March 4th. Robert W. Baird lifted their price target on shares of Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the company a “neutral” rating in a research note on Monday, February 10th. Evercore ISI lifted their price target on shares of Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the company an “outperform” rating in a research note on Monday, February 10th. Finally, Wolfe Research assumed coverage on shares of Mettler-Toledo International in a research note on Friday, December 13th. They issued a “peer perform” rating on the stock. One research analyst has rated the stock with a sell rating, six have given a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, Mettler-Toledo International currently has a consensus rating of “Hold” and a consensus price target of $1,380.50.

Insider Activity

In other news, insider Gerry Keller sold 600 shares of the business’s stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $1,351.34, for a total transaction of $810,804.00. Following the transaction, the insider now owns 6 shares of the company’s stock, valued at approximately $8,108.04. The trade was a 99.01 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Christian Magloth sold 790 shares of the business’s stock in a transaction dated Monday, February 24th. The shares were sold at an average price of $1,313.69, for a total transaction of $1,037,815.10. Following the transaction, the insider now directly owns 734 shares in the company, valued at approximately $964,248.46. The trade was a 51.84 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.94% of the company’s stock.

Mettler-Toledo International Stock Down 0.2 %

Shares of MTD opened at $1,198.09 on Monday. Mettler-Toledo International Inc. has a 52-week low of $1,142.91 and a 52-week high of $1,546.93. The firm’s fifty day moving average is $1,292.72 and its two-hundred day moving average is $1,309.68. The stock has a market cap of $24.97 billion, a PE ratio of 29.56, a price-to-earnings-growth ratio of 3.30 and a beta of 1.15.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share for the quarter, beating the consensus estimate of $11.76 by $0.65. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 591.54%. As a group, research analysts anticipate that Mettler-Toledo International Inc. will post 42.71 earnings per share for the current year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.